跳至主要内容
临床试验/NCT03185156
NCT03185156已完成4 期

The Preventive Effect of Sub Hypnotic Dose of Propofol for Nausea and Vomiting Induced by Hemabate

West China Second University Hospital1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2017年6月28日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
60
试验地点
1
主要终点
The presence of nausea and vomiting

研究概览

简要总结

This is a randomized, placebo-controlled trail, the objective of this study is observation the effect of sub hypnotic dose of propofol for prevention of nausea and vomiting induced by hemabate during spinal anesthesia for elective cesarean section. The primary outcome is the presence of post-delivery intra-operative nausea and vomiting in parturients. The patients demographic characteristics, blood pressure, sensory block level, and the medications will be collected.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Investigator)

入排标准

年龄范围
20 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Patients aged 20-40 years;
  • American Standards Association status I-II.

排除标准

  • Patients with allergy or hypersensitivity to propofol, lipid emulsion, or granisetron;
  • History of nausea or vomiting within 24h before cesarean delivery;
  • History of gastrointestinal or psychiatric disease, motion sickness, smoking, postoperative nausea and vomiting;
  • Morbid obesity;
  • Consumption of drugs such as opioids, antiemetics , H2 antagonists, phenothiazines and/or corticosteroids within 24h before the study period;
  • Any chronic medical or surgical disorders complicating the pregnancy;
  • Conditions contraindicating regional anesthesia.

研究组 & 干预措施

propofol group

Experimental

first dose 0.3mg/Kg propofol, then 1mg/Kg/hr micro-pump

干预措施: Propofol (Drug)

control group

Placebo Comparator

first dose 0.03ml/Kg normal saline, then 0.1ml/Kg/hr micro-pump

干预措施: Normal saline (Drug)

结局指标

主要结局

The presence of nausea and vomiting

时间窗: 24 hours

the patients were not asked directly about nausea during the course of the surgery, but its incidence was recorded when spontaneously reported vomiting was recorded as observed by investigator

次要结局

未报告次要终点

研究者

发起方
West China Second University Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Yanmei-Bi

Principal Investigator

West China Second University Hospital

研究点 (1)

Loading locations...

相似试验